Logo image of ABVC

ABVC BIOPHARMA INC (ABVC) Stock Overview

NASDAQ:ABVC - US00091F3047 - Common Stock

2.83 USD
-0.25 (-8.12%)
Last: 8/29/2025, 8:05:09 PM
2.85 USD
+0.02 (+0.71%)
After Hours: 8/29/2025, 8:05:09 PM

ABVC Key Statistics, Chart & Performance

Key Statistics
52 Week High5.48
52 Week Low0.4
Market Cap66.62M
Shares23.54M
Float20.78M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.19
PEN/A
Fwd PEN/A
Earnings (Next)11-12 2025-11-12
IPO11-09 2004-11-09
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


ABVC short term performance overview.The bars show the price performance of ABVC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 100 200 300

ABVC long term performance overview.The bars show the price performance of ABVC in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 100 200 300

The current stock price of ABVC is 2.83 USD. In the past month the price increased by 2.91%. In the past year, price increased by 319.07%.

ABVC BIOPHARMA INC / ABVC Daily stock chart

ABVC Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.87 371.68B
AMGN AMGEN INC 13.19 154.89B
GILD GILEAD SCIENCES INC 14.6 140.17B
VRTX VERTEX PHARMACEUTICALS INC 23.08 100.25B
REGN REGENERON PHARMACEUTICALS 12.72 61.55B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 58.53B
ARGX ARGENX SE - ADR 76.83 43.59B
ONC BEONE MEDICINES LTD-ADR 6.16 36.38B
INSM INSMED INC N/A 28.77B
BNTX BIONTECH SE-ADR N/A 24.04B
NTRA NATERA INC N/A 23.09B
BIIB BIOGEN INC 8.26 19.38B

About ABVC

Company Profile

ABVC logo image ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The company is headquartered in Fremont, California and currently employs 16 full-time employees. The company went IPO on 2004-11-09. Its pipeline includes ABV-1504, ABV-1505, ABV-1601, ABV-1702, ABV-1703, ABV- 1501, ABV-1519 and ABV-1701. The firm is developing and researching ABV-1504, a botanical reuptake inhibitor that targets norepinephrine to treat Major Depressive Disorder (MDD). ABV-1505 to treat attention deficit hyperactivity disorder (ADHD). The company has developed ABV-1601 for treating depression in cancer patients. ABV-1702 to treat Myelodysplastic syndromes. The company has developed an indication for pancreatic cancer from maitake extract, named ABV-1703. ABV-1501 for the treatment of Triple Negative Breast Cancer. ABV-1701 Vitargus for the treatment of Retinal Detachment or Vitreous Hemorrhage. ABV-1519 for the treatment of Non-Small Cell Lung Cancer. The company also focuses on the development of new drugs and medical devices derived from plants.

Company Info

ABVC BIOPHARMA INC

44370 Old Warm Springs Blvd

Fremont CALIFORNIA US

CEO: Howard Doong

Employees: 18

ABVC Company Website

ABVC Investor Relations

Phone: 15106680881

ABVC BIOPHARMA INC / ABVC FAQ

What is the stock price of ABVC BIOPHARMA INC today?

The current stock price of ABVC is 2.83 USD. The price decreased by -8.12% in the last trading session.


What is the ticker symbol for ABVC BIOPHARMA INC stock?

The exchange symbol of ABVC BIOPHARMA INC is ABVC and it is listed on the Nasdaq exchange.


On which exchange is ABVC stock listed?

ABVC stock is listed on the Nasdaq exchange.


What is ABVC BIOPHARMA INC worth?

ABVC BIOPHARMA INC (ABVC) has a market capitalization of 66.62M USD. This makes ABVC a Micro Cap stock.


How many employees does ABVC BIOPHARMA INC have?

ABVC BIOPHARMA INC (ABVC) currently has 18 employees.


What are the support and resistance levels for ABVC BIOPHARMA INC (ABVC) stock?

ABVC BIOPHARMA INC (ABVC) has a support level at 2.82 and a resistance level at 2.98. Check the full technical report for a detailed analysis of ABVC support and resistance levels.


Should I buy ABVC BIOPHARMA INC (ABVC) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ABVC BIOPHARMA INC (ABVC) stock pay dividends?

ABVC does not pay a dividend.


When does ABVC BIOPHARMA INC (ABVC) report earnings?

ABVC BIOPHARMA INC (ABVC) will report earnings on 2025-11-12.


What is the Price/Earnings (PE) ratio of ABVC BIOPHARMA INC (ABVC)?

ABVC BIOPHARMA INC (ABVC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.19).


What is the Short Interest ratio of ABVC BIOPHARMA INC (ABVC) stock?

The outstanding short interest for ABVC BIOPHARMA INC (ABVC) is 2.97% of its float. Check the ownership tab for more information on the ABVC short interest.


ABVC Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to ABVC. When comparing the yearly performance of all stocks, ABVC is one of the better performing stocks in the market, outperforming 98.78% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ABVC Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to ABVC. ABVC may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ABVC Financial Highlights

Over the last trailing twelve months ABVC reported a non-GAAP Earnings per Share(EPS) of -0.19. The EPS increased by 89.25% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -19.12%
ROE -43.65%
Debt/Equity 0.12
Chartmill High Growth Momentum
EPS Q2Q%-62.5%
Sales Q2Q%-100%
EPS 1Y (TTM)89.25%
Revenue 1Y (TTM)186.88%

ABVC Forecast & Estimates


Analysts
Analysts43.33
Price TargetN/A
EPS Next Y-4.55%
Revenue Next YearN/A

ABVC Ownership

Ownership
Inst Owners2.28%
Ins Owners11.52%
Short Float %2.97%
Short Ratio1.41